BIOGEN INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Biogen Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2010 to Q3 2024.
  • Biogen Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $389M.
  • Biogen Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $1.62B, a 10.5% increase year-over-year.
  • Biogen Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $1.16B, a 61.9% decline from 2022.
  • Biogen Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $3.05B, a 95.8% increase from 2021.
  • Biogen Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $1.56B, a 61.1% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.62B $389M +$457M Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $1.16B $584M -$8M -1.35% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $1.17B $393M +$5.5M +1.42% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-24
Q4 2023 $1.16B $250M -$301M -54.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-14
Q3 2023 $1.46B -$68.1M -$1.2B -106% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $2.66B $592M -$466M -44.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $3.13B $388M +$84.1M +27.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-24
Q4 2022 $3.05B $550M +$182M +49.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-14
Q3 2022 $2.86B $1.13B +$806M +245% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $2.06B $1.06B +$610M +136% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-25
Q1 2022 $1.45B $304M -$106M -25.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-25
Q4 2021 $1.56B $368M +$10.3M +2.88% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-14
Q3 2021 $1.55B $329M -$372M -53.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-25
Q2 2021 $1.92B $449M -$1.09B -70.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-20
Q1 2021 $3.01B $410M -$989M -70.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $4B $358M -$1.08B -75.1% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-03
Q3 2020 $5.08B $702M -$844M -54.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-20
Q2 2020 $5.93B $1.54B +$48M +3.21% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-22
Q1 2020 $5.88B $1.4B -$9.7M -0.69% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-22
Q4 2019 $5.89B $1.44B +$493M +52.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-03
Q3 2019 $5.4B $1.55B +$102M +7.03% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-03
Q2 2019 $5.29B $1.49B +$628M +72.4% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-03
Q1 2019 $4.67B $1.41B +$236M +20.1% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-03
Q4 2018 $4.43B $947M +$1.24B Oct 1, 2018 Dec 31, 2018 10-K 2020-02-06
Q3 2018 $3.19B $1.44B +$218M +17.8% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-06
Q2 2018 $2.97B $867M +$3.8M +0.44% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-06
Q1 2018 $2.96B $1.17B +$425M +56.9% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-06
Q4 2017 $2.54B -$297M -$947M -146% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-06
Q3 2017 $3.49B $1.23B +$193M +18.7% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-06
Q2 2017 $3.29B $863M -$187M -17.8% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-06
Q1 2017 $3.48B $748M -$223M -23% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-06
Q4 2016 $3.7B $649M -$182M -21.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-01
Q3 2016 $3.89B $1.03B +$67.3M +6.97% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-01
Q2 2016 $3.82B $1.05B +$123M +13.2% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-01
Q1 2016 $3.7B $971M +$148M +18% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-01
Q4 2015 $3.55B $832M -$51.9M -5.87% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-02
Q3 2015 $3.6B $966M +$109M +12.7% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-02
Q2 2015 $3.49B $927M +$213M +29.8% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-02
Q1 2015 $3.28B $823M +$343M +71.4% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-02
Q4 2014 $2.93B $884M +$426M +93.2% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-03
Q3 2014 $2.51B $857M +$369M +75.7% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-03
Q2 2014 $2.14B $715M +$224M +45.6% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-03
Q1 2014 $1.92B $480M +$53.3M +12.5% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-03
Q4 2013 $1.86B $457M +$165M +56.6% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-04
Q3 2013 $1.7B $488M +$89.2M +22.4% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-04
Q2 2013 $1.61B $491M +$104M +26.9% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-04
Q1 2013 $1.5B $427M +$124M +41% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-04
Q4 2012 $1.38B $292M -$8.1M -2.7% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-06
Q3 2012 $1.39B $398M +$46.6M +13.2% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-06
Q2 2012 $1.34B $387M +$98.8M +34.3% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-06
Q1 2012 $1.24B $303M +$8.4M +2.85% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-06
Q4 2011 $1.23B $300M +$59.9M +24.9% Oct 1, 2011 Dec 31, 2011 10-K 2013-02-05
Q3 2011 $1.17B $352M +$97.7M +38.4% Jul 1, 2011 Sep 30, 2011 10-K 2013-02-05
Q2 2011 $1.08B $288M -$5.4M -1.84% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-05
Q1 2011 $1.08B $294M +$76.9M +35.4% Jan 1, 2011 Mar 31, 2011 10-K 2013-02-05
Q4 2010 $1.01B $240M Oct 1, 2010 Dec 31, 2010 10-K 2012-02-03
Q3 2010 $254M Jul 1, 2010 Sep 30, 2010 10-K 2012-02-03
Q2 2010 $293M Apr 1, 2010 Jun 30, 2010 10-K 2012-02-03
Q1 2010 $217M Jan 1, 2010 Mar 31, 2010 10-K 2012-02-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.